Disbursements accelerating, margins under pressure
Revenue grew 10.8% YoY and PAT surged 225%, but reported Q2 PAT of just ₹0.9 Cr masks a ₹11.5+ Crore provisioning charge in H1. The company's margin recovery rests on unproven partnership scaling and unexplained reserve normalization.
₹0.9 Cr
+225% YoY, but…
₹12.41 Cr
implies ₹11.5+ Cr reserve charge
1.5%
vs 40.8% operating margin
₹802 Cr
73% secured, on track for ₹1,100–1,200 Cr by Mar 27
On the headline, Moneyboxx's Q2 looks punchy: revenue up 10.8% YoY, PAT up 225%. But beneath lies a puzzle that frames the entire quarter. Pre-provisioning profit in the first half was ₹12.41 Cr; reported PAT just ₹0.9 Cr. That ₹11.5+ Crore gap is management's reserve bill — and they never explained why, or when it normalizes.
The company is executing hard on growth: disbursements have doubled in five months (₹24.5 Cr in Aug → ₹50 Cr in Oct), with ₹100 Cr/month targeted by November. That's real momentum. Four new lending channels — Akshayakalpa (dairy), Bachatt and Loom (digital), and rooftop solar — are live and generating early traction (₹2–17 Cr AUM each). But the path to profitability recovery remains foggy, and the street has taken note: the stock is down 54% from its all-time high, trading below all key moving averages.
The margin mystery
A heavy provisioning charge is not inherently a red flag — conservative accounting can be prudent. But transparency matters. The company's operating metrics are actually strengthening: 90+ PAR fell sharply to 2.56% (from 6.25% in March), collection efficiency stands at 92.5%, and NPA is negligible at 0.01%. So why the reserve bump? Management's silence on this is the quarter's unresolved tension.
We are sitting at a reasonable leverage ratio, which means that funding for next 2, 3 quarters doesn't seem to be a challenge because right now, AUM is ₹800 crores.
What changed on this call
Strong disbursement momentum; ₹50 Cr monthly in Oct.
Confirmed: ₹24.5 Cr (Aug) → ₹32.4 Cr (Sep) → ₹50 Cr (Oct). Math checks for ₹100 Cr target by Nov.
Supported
Secured portfolio increased, improving asset quality.
Secured 73% (Sep 26) vs prior 75% target (slight slip); 90+ PAR 2.56% vs 6.25% (Mar 26). Collections strong at 92.5%.
Partially supported; secured % regressed
AUM on track for ₹1,100–1,200 Cr by March 2027.
AUM ₹802 Cr (Sep 26); requires 38–50% growth in 6 months. Disbursement ramp (₹50 → ₹100 Cr/month) aligns mechanically.
Supported (model-wise)
Partnership-led lending (dairy, digital) will add ₹30–50+ Cr/month.
Akshayakalpa (dairy) ₹2 Cr Sep, targeting ₹25–30 Cr/month by Jan 2027; digital (Bachatt, Loom) ₹2 Cr combined, targeting ₹20–30 Cr by Jan. Early-stage, unproven at scale.
Overstated (optimistic on timing)
Strong funding position; 36 lenders, 12 leading banks, ₹170 Cr liquidity.
Liquidity confirmed; NCD issuance ₹110 Cr (Q2); funding cost up 25–30 bps. Concentration in 12 banks; scaling to ₹1,100+ Cr AUM may strain diversity.
Supported (near-term; risk rising)
Three structural shifts
1. Partnership-led growth is now the story. Secured direct lending (the core MSME business) is still 73% of AUM, but the new engines — dairy (Akshayakalpa with FLDG first-loss guarantee), digital (Bachatt, Loom), and rooftop solar — are meant to accelerate AUM to ₹1,100–1,200 Cr by March 2027. Management is confident; the market is not. These channels are early-stage, sourced through partners, and untested in a macro slowdown.
2. Secured portfolio target has regressed. Prior guidance was 80% secured by March 2027; current standing is 73%. The shift reflects deliberate strategy (unsecured and partnerships yield higher spreads) but introduces concentration risk into new, high-growth segments. If macro deteriorates or partner execution stumbles, PAR could spike.
3. Operating leverage gains are being reinvested, not harvested. TAT halved via the Moneyboxx ONE LOS (from ~10 days to 6.5–7 days), Cattle AI is reducing manual screening by 30–40%, and opex/AUM is 14.3% (target <10% by 2028). All these savings are plowed into branch expansion and partnership ramp. The margin recovery the company needs is still 2–3 quarters away, if it happens at all.
Risk ledger
Profitability path opaque; heavy provisioning drag (₹11.5 Cr H1) unexplained.
HighPre-prov PAT ₹12.41 Cr H1 vs reported ₹0.9 Cr. Lack of management disclosure on reserve driver or normalization timeline erodes confidence in margin recovery.
Partnership execution risk; dairy, digital, solar channels unproven at scale.
HighAkshayakalpa targeting ₹25–30 Cr/month by Jan 2027 (from ₹2 Cr Sep); Bachatt/Loom aiming ₹20–30 Cr/month. Customer acquisition, churn, and credit quality are unvalidated.
Secured portfolio declined; unsecured/partnership mix rising.
MediumSecured 73% vs 75% prior target. New channels have higher yields but also higher risk. If macro deteriorates, PAR could spike and unwind gains in collection efficiency.
Funding cost inflation and lender concentration.
MediumBorrowing rates up 25–30 bps; 36 lenders with 12 leading banks. Scaling to ₹1,100–1,200 Cr AUM may strain funding diversity; capital market access still limited.
Asset quality deterioration in macro slowdown.
MediumCurrent PAR/NPA metrics are strong (90+ PAR 2.56%, NPA 0.01%). But rapid growth into unsecured/partnership lending with small-ticket MSME (avg ₹6.7 lakh) could see collections pressure if external shocks hit borrower cash flows.
How the street is positioned
Price & drawdown: The stock trades at ₹41.5, down 54% from its all-time high of ₹91.5. It is trading below its 20-day (₹47.68), 50-day (₹52.57), and 200-day (₹61.9) moving averages — a steep drawdown on a multi-timeframe basis. The 52-week range is ₹35.85–₹91.5; the stock is off the lows by only 15.76%, suggesting weak conviction. RSI is 38.9 (neutral), and volume is declining. The market's verdict on the quarter is skeptical: growth alone is not enough without margin visibility.
Institutional flow: FII ownership is 0.00% (Q1 FY27), unchanged from prior quarters. DII has been near 0% historically. Promoter ownership stands steady at 46.79%. The absence of institutional buying despite growth acceleration underscores concern over profitability and execution risk. No bulk trades are reported, but the lack of institutional momentum on a 54% drawdown is itself a signal: sophisticated money sees risk, not a bargain.
The debate
What to watch next
1 · Monthly disbursement hit ₹100 Cr by Nov 2026?
October was ₹50 Cr. November's run-rate (to be reported in Q3 earnings, likely Jan 2027) is the first hard check on partnership ramp credibility. If it stalls at ₹60–70 Cr, March 2027 AUM target is at risk.
2 · Q3 pre-prov PAT and reserve rate guidance.
The ₹11.5 Cr provisioning charge in H1 is the elephant in the room. Does management disclose the reserve driver and normalize the rate, or does it remain opaque? This determines whether profitability recovery is credible or stalled.
3 · Secured portfolio stabilization or further decline?
Secured is now 73% vs 75% prior. If it drops below 70% by March 2027, the strategy shift toward unsecured/partnerships is confirmed, raising refinance risk.
Valuation & near-term
Moneyboxx is not yet a profitable growth story — it's a growth story seeking profitability. The 54% drawdown from ATH is overdone if the company executes on disbursement targets and stabilizes margins above 5% by March 2027. It is justified if partnerships fail or reserve pressure persists. At ₹41.5, the stock is pricing in material execution risk. The question is whether that risk premium (vs. peers' forward earnings multiples on proven profitability) is warranted.
Moneyboxx's Q2 confirms strong execution on disbursement acceleration and credit quality improvement. But it also surfaces a profitability puzzle that management has not addressed. The ₹11.5+ Crore provisioning charge in H1 — and its trajectory in Q3 and Q4 — is the single number that determines whether the march to ₹1,100+ Cr AUM yields margin recovery or just asset-heavy stagnation.
The street is right to be skeptical until that gap closes. Hold for now; upgrade only if Q3 brings clarity on reserves and partnership execution validates the new growth drivers. The number to track: pre-prov PAT in Q3 FY27, and management's guidance on reserve normalization.
Moneyboxx PAT swings to ₹0.91 Cr on loan-sale gain; core lending book posts a loss
PAT +225.42% YoY · revenue +10.85% · margins expanding
₹60.96 Cr
+10.85% YoY
₹0.91 Cr
+225.42% YoY
1.49%
+1pp YoY
₹0.16
Moneyboxx Finance's standalone Q2 FY27 (quarter ended September 30, 2026) PAT of ₹0.91 Cr is up 225% YoY (from ₹0.28 Cr) and 338% QoQ (from ₹0.21 Cr), on revenue from operations of ₹60.96 Cr (+10.8% YoY, +17.2% QoQ). But almost the entire print is manufactured by a single line: a ₹16.67 Cr "net gain on derecognition of financial instruments" — the accounting gain booked when the company sells down loans via assignment/co-lending. Strip that gain out and pre-tax profit turns into a loss of roughly ₹15.66 Cr for the quarter, versus adjusted losses of ₹3.84 Cr last quarter and just ₹0.42 Cr a year ago — the core lending book's underlying loss has widened roughly 34-fold YoY even as the headline print looks like a beat. Reported net profit margin improved to 1.49% of total income (self-disclosed, vs 0.40% last quarter and 0.51% a year ago), but that expansion is entirely a function of the gain-on-sale line, not operating leverage in the lending business.
Q2 FY-2027 vs prior quarters
The ex-gain picture is explained on the cost side too: impairment on financial instruments jumped to ₹8.96 Cr from ₹2.19 Cr QoQ and ₹5.27 Cr YoY, which lines up with the ₹6.37 Cr loss booked on selling ₹29.26 Cr of stressed loans (2,276 accounts) to an ARC this quarter — a deliberate balance-sheet clean-up rather than an operating deterioration. That sale, plus continued assignment of performing loans, is also why reported Gross/Net Stage-3 ratios fell to a pristine 0.01%/0.00% (self-disclosed) — stress has been sold off the book, not resolved through recoveries. Employee costs (₹22.12 Cr) and other expenses (₹5.02 Cr) were broadly stable sequentially and YoY, so the swing in profitability sits almost entirely on the revenue-recognition and impairment lines, not the cost base.
The stock went into the print at ₹39.1, down 33.5% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters; revenue is at a 6-quarter high.
What the summary numbers don't show
EPS ₹0.16 (basic & diluted) vs ₹0.03 last quarter and ₹0.09 a year ago.
Target 80% secured portfolio by March 2027 (on track, currently 75%). Aim to reach 10% AUM in renewable energy by FY27 (~₹80–85 Cr). Normalize disbursements by January 2027 (Q4 FY27). Expect institutional equity infusion in H2 FY27.
Total assets crossed ₹1,056.9 Cr as of September 30 (from ₹995.3 Cr at FY26-end), funded partly by the ₹60 Cr NCD raise on September 28 and ₹84 Cr of fresh debt facilities secured on October 1 — debt-equity stands at 2.44x and CRAR at a comfortable 26.35%. Equity capital was flat quarter-on-quarter (₹69.82 Cr vs ₹69.81 Cr), so management's guided H2 FY27 institutional equity infusion (from the August 18 concall) has not yet materialised — that half (Oct 2026-Mar 2027) is still ahead. The other prior checkpoints — 80% secured portfolio by March 2027 (75% as of the last concall) and 10% AUM in renewables by FY27 — are not disclosed in this filing, so progress is unknown rather than met or missed; disbursements normalizing by Q4 FY27 is also not yet due, though the company's own post-quarter update flagged monthly disbursements crossing ₹50 Cr in October. No street estimates for this specific quarter turned up in search, and the company has not issued press-release commentary on this print at the time of this analysis, so there is no management framing to reconcile against the numbers above.
W1
Whether the ₹16.67 Cr loan-assignment/derecognition gain recurs next quarter, or the core lending book continues posting a loss (adjusted PBT was -₹15.66 Cr this quarter).
W2
Progress on the 80% secured-portfolio target by March 2027 (75% as of the last concall) — not disclosed this quarter.
W3
The guided institutional equity infusion in H2 FY27 (Oct 2026-Mar 2027) — equity capital still unchanged as of Q2.
Converted from ₹ Lakhs; standalone only (no consolidated statement filed). PAT is almost entirely a ₹16.67 Cr net gain on derecognition of financial instruments (loan assignment/ARC sale) — ex-gain PBT is a loss of ~₹15.66 Cr. Tax is ₹0.11 Cr deferred tax only (no current tax). Figures tie exactly to the company's own ratio disclosures (NPM 1.49%, EPS 0.16, debt-equity 2.44, CRAR 26.35%).
Strong disbursement ramp masks thin profitability
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Secured portfolio 73% vs prior 75% target (slight slip); secured AUM growth and collection efficiency (92.5%) on track; no prior numeric guidance explicitly cut, but secured % regressed.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Management executing on core MSME lending with meaningful disbursement acceleration (INR24.5→50 Cr monthly in 5 months) and new channels live; however, thin profitability (PAT ₹0.9 Cr on ₹61 Cr revenue) despite claimed pre-provisioning PAT ₹12.41 Cr H1 signals high provisioning burden or operating leverage shortfall that management did not reconcile. AUM growth path to ₹1,100–1,200 Cr by March 27 is credible mechanically, but margin recovery trajectory unclear.
₹61 Cr
Revenue · +10.8% YoY₹0.9 Cr
Reported PAT · +225.4% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Strong disbursement momentum; monthly running rate INR50 Cr in Oct
OVERSTATEDQ2 total income ₹61 Cr; PAT only ₹0.9 Cr (1.5% margin) vs claimed pre-prov PAT ₹12.41 Cr H1
Secured portfolio increased, improving asset quality
METSecured 73% Sep 26 vs prior target 75%; 90+ PAR 2.56% (vs 6.25% March) shows improvement
AUM INR802 Cr at end-Sep, targeting INR1,100–1,200 Cr by March 27
MET38% AUM growth in 6 months needed; disbursement acceleration (INR50→100 Cr/month) aligns with math
Earnings quality
What changed since the last call
Secured portfolio target regressed
DowngradeSecured 73% Sep 26 vs 75% prior target; reflects shift toward unsecured/partnership channels (dairy, solar, digital) to accelerate AUM growth.
Partnership-led channels live
NewAkshayakalpa (dairy), Bachatt (digital), Loom (upcoming) are new growth engines; not previously disclosed; early traction INR2–5 Cr/month but unproven at scale.
Monthly disbursement run-rate doubled
UpgradeINR24.5 Cr (Aug) → INR50 Cr (Oct); management targeting INR100 Cr by Nov 2026, vs prior steady-state ~₹20 Cr/month.
Pre-provisioning profitability opaque
DowngradePre-prov PAT ₹12.41 Cr H1 but reported PAT ₹0.9 Cr suggests ₹11.5+ Cr provisioning; management did not clarify why or guide future provision rates.
The Q&A
Analysts pressed hard on funding sufficiency, asset quality, and disbursement sustainability; management held firm on liquidity (INR170 Cr buffer, 36 lenders), cited improving 90+ PAR (2.56%), and acknowledged funding costs up 25–30 bps but dismissed as near-term headwind. Q&A revealed management's confidence in partnership ramp but lack of detail on profitability path.
Funding & liquidity — Riya Shah, Shah Family Office
AnsweredStrong liquidity INR170 Cr; 36 lenders with 12 leading banks; AUM INR800 Cr provides buffer for 2–3 quarters; NCD issuance INR110 Cr in Q2; capital adequacy 26.35% supports growth.
Profitability & AUM growth — Riya Shah, Shah Family Office
AnsweredFocus on AUM growth through higher branch productivity, partnership scaling, portfolio quality improvement, and operating leverage; targets INR1,100–1,200 Cr AUM by March 27.
Disbursement sustainability — Chinmay Parab, Individual Investor
PartialINR50 Cr disbursed Oct; partnership-led ramp (Akshayakalpa, Loom) expected to add INR30–50+ Cr/month by Jan 2027; INR100 Cr target feasible but will take time as partnerships settle.
Akshayakalpa dairy partnership — Chinmay Parab, Individual Investor
AnsweredStarted Sep 2026; INR2 Cr disbursed end-Sep; targeting INR25–30 Cr/month by Jan 2027; one of multiple partnerships to diversify.
Rooftop solar financing — Chinmay Parab, Individual Investor
AnsweredSolar AUM INR17 Cr (Sep); target INR25 Cr/month in future disbursements; yield 22.7%; leveraging OEM/EPC partnerships for sourcing.
Secured vs unsecured split — Rutvi, Individual Investor
AnsweredSecured 73% of AUM; unsecured lower spread but FLDG covers 10% first loss; partnerships help in collections; opex lower on secured due to 4-year tenor.
Technology efficiency gains — Rutvi, Individual Investor
AnsweredLOS (Moneyboxx ONE) launched May 2026; TAT reduced 10–11 days → 6.5–7 days; Cattle AI reducing manual screening 30–40%; data analytics improving geographic targeting and lead quality.
Guidance
AUM ₹1,100–1,200 Cr by March 2027
MediumFrom ₹802 Cr (Sep 26); requires 38–50% growth in 6 months; disbursement acceleration (INR50→100 Cr/month) aligns mechanically
Monthly disbursements INR100 Cr by Nov 2026
MediumINR50 Cr Oct 2026; partnerships ramping; unproven at scale
Opex/AUM ratio below 10% over next 2 years
LowCurrently 14.3% (H1); moderation linked to operating leverage; no explicit profitability target given
Net interest margin stable at ~11.9%
MediumLending IRR 24.8%, borrowing 12.7%; margin pressure from competitive funding and unsecured/partnership mix shift
Risks the call surfaced
Profitability headwind
HighPre-provisioning PAT ₹12.41 Cr H1 vs reported PAT ₹0.9 Cr (93% reserve impact). Heavy provisioning suggests asset quality stress or conservatism; no management guidance on trajectory.
Partnership execution risk
MediumAkshayakalpa (dairy), Bachatt/Loom (digital), rooftop solar all early-stage; combined targeting ₹80+ Cr/month by Jan 2027; customer acquisition, retention, and credit quality untested at scale.
Funding & liquidity
Medium36 lenders (12 leading banks); AUM INR800 Cr; funding cost up 25–30 bps; rapid AUM growth to ₹1,100–1,200 Cr may strain funding diversity; capital market access uncertain.
Asset quality deterioration
MediumRapid unsecured/partnership portfolio growth (dairy, digital, solar) via new channels; early-stage vintage unpredictable; 90+ PAR improved to 2.56% but macro slowdown could reverse gains.
Secured portfolio regression
LowSecured 73% Sep 26 vs 75% prior target; shift toward unsecured/partnerships to accelerate AUM may increase risk profile if macro deteriorates.
Management
Score 7/10. Clear on operations (branch count, AUM, disbursement pipeline) and detailed on segment breakdown; opaque on provisioning/profitability path and partnership ramp-up timing. Track record mixed: AUM/disbursement growth on pace (INR50 Cr monthly Oct vs INR24.5 in Aug); secured portfolio target regressed (73% vs 75%); pre-prov profit strong but reported profit weak.
1 · Nov 2026
Monthly disbursement rate INR100 Cr (up from INR50 Cr Oct)
2 · Dec 2026
Partnership-led channels (dairy, digital) scale to ₹30+ Cr/month combined
3 · Jan 2027
Monthly disbursements normalize to high run-rate; provisioning pressure may ease
AUM growth path to ₹1,100–1,200 Cr by March 27 is credible mechanically, but margin recovery trajectory unclear.